ArticleCureus2026

Tumor Regression Following Neoadjuvant Therapy as a Determinant of Surgical Resectability in Stage IIIA Non-small Cell Lung Cancer: A Comparative Clinical Study.

Safet Musanovic et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.